Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05893940 · ClinicalTrials.gov registry record · NA

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

A NA study of Hematopoietic and Lymphoid System Neoplasm, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05893940 is a NA study of Hematopoietic and Lymphoid System Neoplasm that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 75 participants, below the 1,356-participant average among 31 other Hematopoietic and Lymphoid System Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05893940, a NA study of Hematopoietic and Lymphoid System Neoplasm, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This clinical trial tests the effect of low-intensity mechanical stimulation (LIMS) vibration therapy in patients with hematologic malignancies. Patients with hematologic malignancies often undergo a blood and/or bone marrow transplant (hematopoietic cell transplantation \[HCT\]) or cellular therapy. The LIMS board delivers vibrations through the bones that may stimulate bone growth and may also increase muscle activity and strength and may also increase T-cell activation in patients planning to undergo cellular therapy. LIMS vibration therapy may stop or reverse BMD loss and/or improve the development of T-cells in the body in patients with hematologic malignancies who are undergoing or may plan to undergo HCT or cellular therapies.

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Dual X-ray Absorptiometry
  • PROCEDURE Low Intensity Vibration Therapy

Study Locations (1)

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2023-08-14
Est. Completion 2026-09-01
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT05893940

The ClinicalTrials.gov registry entry for NCT05893940 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,356-participant average among 31 other Hematopoietic and Lymphoid System Neoplasm trials with a reported enrollment target (94% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hematopoietic and Lymphoid System Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT05893940 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05893940 about?

NCT05893940 is a clinical study titled "Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients". This clinical trial tests the effect of low-intensity mechanical stimulation (LIMS) vibration therapy in patients with hematologic malignancies. Patients with hematologic malignancies often undergo a blood and/or bone marrow transplant (hematopoietic cell transplantation \[HCT\]) or cellular therapy...

What is the current status of trial NCT05893940?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2023-08-14. Estimated completion is 2026-09-01.

What conditions does trial NCT05893940 study?

This clinical trial studies the following conditions: Hematopoietic and Lymphoid System Neoplasm.

What interventions are being tested in trial NCT05893940?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Dual X-ray Absorptiometry (PROCEDURE), Low Intensity Vibration Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT05893940?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05893940 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic and Lymphoid System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.